Table 1.
Patient Identification | Sex | Age at Baseline | Viral Load study entry (copies/ml) | Viral Load study exit (copies/ml) | CD4 T-cell count study entry (cells/μl) | CD4 T-cell count study exit (cells/μl) | CD4 T-cell decline rate (cells/μl/ per month) |
---|---|---|---|---|---|---|---|
SK010 | F | 31 | 6,480 | 345,000 | 649 | 268 | −10 |
SK035 | F | 31 | 5,800 | 2,950 | 680 | 322 | −7 |
SK036 | M | 32 | 5,100 | 10,600 | 936 | 575 | −7 |
SK169 | F | 30 | 2,210 | 2,440 | 561 | 437 | −4 |
SK200 | F | 40 | 14,360 | 24,900 | 595 | 416 | −7 |
SK221 | F | 30 | 9,740 | 23,700 | 503 | 297 | −3 |
SK233 | F | 22 | 11,800 | 18,900 | 547 | 218 | −8 |
SK312 | F | 59 | 3,460 | 3,630 | 545 | 881 | −9 |